Cabaletta Bio to Participate in Upcoming Investor Conferences

Cabaletta Bio (Nasdaq: CABA) will participate in four September 2026 healthcare and investment conferences, including events hosted by Wells Fargo, Cantor, Morgan Stanley, and H.C.

Rhea-AI Summary

Cabaletta Bio (Nasdaq: CABA) will participate in four September 2026 healthcare and investment conferences, including events hosted by Wells Fargo, Cantor, Morgan Stanley, and H.C. Wainwright. The company will hold investor meetings and several webcasted fireside chats, which will be accessible via the News and Events section of its website with replays available for 30 days.

News Market Reaction – CABA

+6.11% 63.2x vol

31 alerts

+6.11% Session close to close

+20.0% Peak Tracked

-4.3% Trough Tracked

$606.40M Market Cap

63.2x Rel. Volume

In the Sep 1 session, CABA gained 6.11%, reflecting a notable positive market reaction. Argus tracked a peak move of +20.0% during that session. Argus tracked a trough of -4.3% from its starting point during tracking. Our momentum scanner triggered 31 alerts that day, indicating elevated trading interest and price volatility. Trading volume was exceptionally heavy at 63.2x the daily average, suggesting very strong buying interest.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PHILADELPHIA, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced its participation in the following upcoming investor conferences:

• Wells Fargo 21st Annual Healthcare Conference: Meetings with investors on Tuesday, September 8, 2026, in Boston, MA.
  
  
• 2026 Cantor Global Healthcare Conference: Meetings with investors and a webcasted fireside chat at 8:35 a.m. ET on Wednesday, September 9, 2026, in New York, NY.
  
  
• Morgan Stanley 24th Annual Global Healthcare Conference: Meetings with investors and a webcasted fireside chat at 10:45 a.m. ET on Monday, September 14, 2026, in New York, NY.
  
  
• H.C. Wainwright 28th Annual Global Investment Conference: Meetings with investors and a fireside chat at 8:30 a.m. ET on Wednesday, September 16, 2026, in New York, NY.
  
  

The webcasted fireside chats will be available on the News and Events section of the Company’s website at www.cabalettabio.com. Archived replays will be available for 30 days.

About Cabaletta Bio
Cabaletta Bio (Nasdaq: CABA) is a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically for patients with autoimmune diseases. Cabaletta’s lead product candidate, rese-cel, is an investigational 4-1BB-containing fully human CD19-CAR T cell therapy being advanced across the RESET™ (REstoring SElf-Tolerance) clinical development program spanning multiple therapeutic areas, including rheumatology, neurology, and dermatology. Cabaletta Bio’s headquarters and labs are located in Philadelphia, PA. For more information, visit www.cabalettabio.com and connect with us on LinkedIn.

Contacts
Investors: investors@cabalettabio.com
Media: media@cabalettabio.com

FAQ

When will Cabaletta Bio (CABA) attend the Wells Fargo 21st Annual Healthcare Conference in 2026?

Cabaletta Bio will hold investor meetings at the Wells Fargo 21st Annual Healthcare Conference on Tuesday, September 8, 2026, in Boston, MA. According to Cabaletta Bio, this appearance is part of a series of September investor conference engagements.

What is the date and time of Cabaletta Bio's webcast at the 2026 Cantor Global Healthcare Conference?

Cabaletta Bio will host a webcasted fireside chat at the 2026 Cantor Global Healthcare Conference at 8:35 a.m. ET on Wednesday, September 9, 2026, in New York, NY. According to Cabaletta Bio, investor meetings will also occur at this event.

When is Cabaletta Bio's Morgan Stanley 24th Annual Global Healthcare Conference fireside chat in 2026?

Cabaletta Bio will participate in a webcasted fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference at 10:45 a.m. ET on Monday, September 14, 2026, in New York, NY. According to Cabaletta Bio, the company will also conduct investor meetings there.

What are the details of Cabaletta Bio's appearance at the H.C. Wainwright 28th Annual Global Investment Conference 2026?

Cabaletta Bio will have investor meetings and a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference at 8:30 a.m. ET on Wednesday, September 16, 2026, in New York, NY. According to Cabaletta Bio, this session will be one of several September investor events.

How can investors access Cabaletta Bio (CABA) webcasted fireside chats from the September 2026 conferences?

Investors can access Cabaletta Bio’s webcasted fireside chats via the News and Events section of www.cabalettabio.com. According to Cabaletta Bio, archived replays of these webcasts will remain available for 30 days after the events.

Will replays of Cabaletta Bio's September 2026 investor conference webcasts be available?

Yes. Cabaletta Bio will provide archived replays of its September 2026 webcasted fireside chats for 30 days on its website. According to Cabaletta Bio, these replays will be accessible through the News and Events section.